Weinberg v. Gold

838 F. Supp. 2d 355, 2012 U.S. Dist. LEXIS 32449
CourtDistrict Court, D. Maryland
DecidedMarch 12, 2012
DocketCivil No. JKB-11-3116
StatusPublished
Cited by8 cases

This text of 838 F. Supp. 2d 355 (Weinberg v. Gold) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Weinberg v. Gold, 838 F. Supp. 2d 355, 2012 U.S. Dist. LEXIS 32449 (D. Md. 2012).

Opinion

MEMORANDUM

JAMES K. BREDAR, District Judge.

Plaintiff Arnold Weinberg has brought this shareholder’s derivative suit on behalf of BioMed Realty Trust, Inc., against various officers and directors of the company, alleging issuance of a false and misleading proxy statement in violation of section 14(a) of the Securities Exchange Act of 1934, breach of fiduciary duty, and unjust enrichment. (Compl., ECF No. 1.) The complaint indicates the pivotal event leading to this lawsuit was a “say on pay” vote1 by the shareholders on May 25, 2011, in which a majority of the shares voted rejected the 2010 executive compensation plan. (Id. ¶ 4.) The plan was formulated by a three-member compensation committee of directors and approved by the board. (Id. ¶¶ 20-25.) Following the shareholders’ vote, the board did not rescind its approval of the compensation plan. (Id. ¶ 6.)

Pending before the Court are two motions to dismiss for failure to state a claim. The first motion (ECF No. 14) was filed by BioMed and seeks dismissal on the ground that Weinberg failed to plead sufficient factual allegations to justify his filing suit without first making a demand on the company to pursue this litigation. The second motion (ECF No. 15) was filed by the individual defendants asserting the complaint fails to state a claim because no allegations show that the executive compensation decision was reached contrary to the business judgment rule, because no allegations show either a materially false statement or a material omission of fact in the proxy statement, and because no allegations permit a conclusion that it would be inequitable for BioMed’s executives to retain their 2010 compensation. A hearing is unnecessary. Local Rule 105.6 (D. Md. 2011). The first motion will be granted and the second motion will be denied as moot.

J. Standard of Dismissal for Failure to State a Claim

A complaint must contain “sufficient factual matter, accepted as true, to ‘state a [357]*357claim to relief that is plausible on its face.’ ” Ashcroft v. Iqbal, 556 U.S. 662, 129 S.Ct. 1937, 1949, 173 L.Ed.2d 868 (2009) (quoting Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007)). Facial plausibility exists “when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Iqbal, 129 S.Ct. at 1949. An inference of a mere possibility of misconduct is not sufficient to support a plausible claim. Id. at 1950. As the Twombly opinion stated, “Factual allegations must be enough to raise a right to relief above the speculative level.” 550 U.S. at 555, 127 S.Ct. 1955.

In addition to the governing standard of Rule 12(b)(6), Rule 23.1(b) sets forth pleading requirements for a shareholders’ derivative suit. In pertinent part, Rule 23.1(b)(3) requires that the complaint state with particularity:

(A) any effort by the plaintiff to obtain the desired action from the directors or comparable authority and, if necessary, from the shareholders or members; and
(B) the reasons for not obtaining the action or not making the effort.

II. Demand Futility

A. Legal Standards

Rule 23.1 only sets forth a pleading requirement and “does not create a demand requirement of any particular dimension.” Kamen v. Kemper Fin. Servs., Inc., 500 U.S. 90, 95, 111 S.Ct. 1711, 114 L.Ed.2d 152 (1991) (emphasis omitted). At common law, the equitable invention of a shareholder’s derivative suit was accompanied by a requirement “that the shareholder demonstrate ‘that the corporation itself had refused to proceed after suitable demand, unless excused by extraordinary conditions.’ ” Id. at 95-96, 111 S.Ct. 1711 (citation omitted).

The purpose of the demand requirement is to “affor[d] the directors an opportunity to exercise their reasonable business judgment and ‘waive a legal right vested in the corporation in the belief that its best interests will be promoted by not insisting on such right.’ ” Ordinarily, it is only when demand is excused that the shareholder enjoys the right to initiate “suit on behalf of his corporation in disregard of the directors’ wishes.” In our view, the function of the demand doctrine in delimiting the respective powers of the individual shareholder and of the directors to control corporate litigation clearly is a matter of “substance,” not “procedure.”

Id. at 96-97, 111 S.Ct. 1711 (alteration in original; citations omitted). Thus, the standard for excusing demand is defined in a federal derivative action by the law of the State of incorporation. See id. at 108-09, 111 S.Ct. 1711 (holding so in relation to derivative suit under Investment Company Act of 1940).

BioMed is a Maryland corporation with its principal place of business in California. (Compl. ¶ 15.) Therefore, this Court must look to Maryland law to determine whether demand should be excused in this case. The decision of the Maryland Court of Appeals in Werbowsky v. Collomb, 362 Md. 581, 766 A.2d 123 (2001), is the most recent, authoritative exposition of Maryland law on the issue of demand futility.

The Werbowsky court reviewed at length the evolution of the standard for demand futility both in Maryland and beyond. In Maryland, the issue remains governed by common law, although a number of other jurisdictions have enacted the demand requirement and exception into statutory law. Moreover, the trend out[358]*358side of Maryland has been either to eliminate the exception or to define it in a way that appears aimed at reducing its availability. 766 A.2d at 137. But in considering the various standards for demand futility, the court declined to adopt either the Delaware approach or the models proposed by the American Bar Association (“ABA”) and the American Law Institute (“ALI”). Id. at 143.

The Delaware standard is formulated thusly:

[Whether] a reasonable doubt is created that: (1) the directors are disinterested and independent and (2) the challenged transaction was otherwise the product of a valid exercise of business judgment.

Aronson v. Lewis, 473 A.2d 805, 814 (Del. 1984), overruled on other grounds by Brehm v. Eisner, 746 A.2d 244 (Del.2000), quoted in Werbowsky, 766 A.2d at 139.

The ABA standard is contained in the Model Business Corporation Act:

No shareholder may commence a derivative proceeding until:

(1) a written demand has been made upon the corporation to take suitable action; and

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Nathanson v. Tortoise Capital Advisors
Court of Special Appeals of Maryland, 2025
Epstein v. Ruane, Cunniff & Goldfarb Inc.
2018 NY Slip Op 4970 (Appellate Division of the Supreme Court of New York, 2018)
Gordon v. Sznewajs
357 F. Supp. 3d 1009 (C.D. California, 2018)
In re Res. Capital Corp., S'holder Derivative Litig.
286 F. Supp. 3d 619 (S.D. Illinois, 2018)
Morefield v. Bailey
959 F. Supp. 2d 887 (E.D. Virginia, 2013)
Raul v. Rynd
929 F. Supp. 2d 333 (D. Delaware, 2013)
Boxer v. Accuray Inc.
906 F. Supp. 2d 1012 (N.D. California, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
838 F. Supp. 2d 355, 2012 U.S. Dist. LEXIS 32449, Counsel Stack Legal Research, https://law.counselstack.com/opinion/weinberg-v-gold-mdd-2012.